Calibration, calculation, and prescription issues in permanent prostate brachytherapy with (103)Pd.
作者信息
Bice W S, Prestidge B R, Sarosdy M F
出版信息
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):289-91. doi: 10.1016/s0360-3016(00)00805-1.
Abstract
摘要
相似文献
1
Calibration, calculation, and prescription issues in permanent prostate brachytherapy with (103)Pd.
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):289-91. doi: 10.1016/s0360-3016(00)00805-1.
2
125 Gy or 135 Gy? Comments on the American Brachytherapy Society article by Beyer et al. IJROBP 2000;47:273-275.
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):897-8. doi: 10.1016/s0360-3016(00)01391-2.
3
In regard to the American Brachytherapy Society recommendations for 103palladium brachytherapy. Beyer et al. IJROBP 2000;47:273-275.
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):899. doi: 10.1016/s0360-3016(00)01393-6.
4
American Brachytherapy Society recommendations for clinical implementation of NIST-1999 standards for palladium-103 brachytherapy: in regard to Beyer et al. IJROBP 2000;47:273-275.
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):898-9; author reply 899. doi: 10.1016/s0360-3016(00)00796-3.
5
In regard to Beyer, Nath, and Butler et al. IJROBP 2000;47:273-275.
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):900. doi: 10.1016/s0360-3016(00)01392-4.
6
Regarding Blasko et al. palladium-103 brachytherapy for prostate carcinoma. IJROBP 2000;46:839-850.
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1267. doi: 10.1016/s0360-3016(00)00704-5.
7
103Pd brachytherapy dose prescription.
Med Phys. 1999 Sep;26(9):2034-5. doi: 10.1118/1.598708.
8
The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy.
Brachytherapy. 2017 Jan-Feb;16(1):68-74. doi: 10.1016/j.brachy.2016.06.013.
9
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103.
Brachytherapy. 2007 Jan-Mar;6(1):34-7. doi: 10.1016/j.brachy.2006.11.001.
10
[Evolution of prostate cancer brachytherapy].
Bull Cancer. 2012 Dec;99(12):1175-81. doi: 10.1684/bdc.2012.1668.
Zotero 插件